The Erythropoietin Promoter Variant rs1617640 Is Not Associated with Severe Retinopathy of Prematurity, Independent of Treatment with Erythropoietin.

Christof Dame,Lina K Sciesielski, Carolin Rau,Chiara-Aiyleen Badur,Christoph Bührer

The Journal of Pediatrics（2018）

引用 8|浏览8

暂无评分

摘要

In this case-control study, the erythropoietin (EPO) promoter variant s1617640, linked to high intravitreal EPO concentrations and increased risk of diabetic retinopathy, was not associated with severe retinopathy of prematurity. This finding was observed both in infants with and without recombinant EPO administration.

查看译文

关键词

ROP,EPO,PCR,rEPO,VLBW

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要